These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1576590)

  • 1. Synergistic inhibition of human gastric carcinoma cell growth by 1-beta-D-arabinofuranosylcytosine and hydroxyurea or 2'-deoxyguanosine in vitro.
    Matsumoto M; Kawahara T; Tsuda M; Ohkubo T; Kamiguchi H; Yamamura M
    Cancer Lett; 1992 Apr; 63(3):221-8. PubMed ID: 1576590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of synergistic cell killing by hydroxyurea and cytosine arabinoside.
    Tanaka M; Kimura K; Yoshida S
    Jpn J Cancer Res; 1985 Aug; 76(8):729-35. PubMed ID: 3930450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic inhibition of human leukemia cell growth by deoxyguanosine and 1-beta-D-arabinofuranosylcytosine.
    Akman SA; Ross DD; Joneckis CC; Fox BM; Bachur NR
    Biochem Pharmacol; 1984 Apr; 33(7):1059-63. PubMed ID: 6712715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of ara-C induced cytotoxicity by hydroxyurea in LoVo colon carcinoma cells.
    Robichaud NJ; Fram RJ
    Biochem Pharmacol; 1987 May; 36(10):1673-7. PubMed ID: 3109427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic interaction between 1-beta-D-arabinofuranosylcytosine, thymidine, and hydroxyurea against human B cells and leukemic blasts in vitro.
    Streifel JA; Howell SB
    Proc Natl Acad Sci U S A; 1981 Aug; 78(8):5132-6. PubMed ID: 6975478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of methotrexate and 1-beta-D-arabinofuranosylcytosine on pools of deoxyribonucleoside triphosphates in L1210 ascites cells.
    Roberts D; Peck C
    Cancer Res; 1981 Feb; 41(2):505-10. PubMed ID: 7448798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of thymidine and hydroxyurea on the metabolism and cytotoxicity of 1-B-D arabinofuranosylcytosine in highly resistant human leukemia cells.
    Bhalla K; Swerdlow P; Grant S
    Blood; 1991 Dec; 78(11):2937-44. PubMed ID: 1954383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1-beta-D-arabinofuranosylcytosine and hydroxyurea production of cytotoxic synergy with cis-diamminedichloroplatinum(II) and modification of platinum-induced DNA interstrand cross-linking.
    Swinnen LJ; Barnes DM; Fisher SG; Albain KS; Fisher RI; Erickson LC
    Cancer Res; 1989 Mar; 49(6):1383-9. PubMed ID: 2924295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of ribonucleotide reductase by a new class of isoindole derivatives: drug synergism with cytarabine (Ara-C) and induction of cellular apoptosis.
    Nandy P; Lien EJ; Avramis VI
    Anticancer Res; 1999; 19(3A):1625-33. PubMed ID: 10470093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the cellular pharmacology and clinical toxicity of 1-beta-D-arabinofuranosylcytosine.
    Howell SB; Streifel JA; Pfeifle CE
    Med Pediatr Oncol; 1982; 10 Suppl 1():81-91. PubMed ID: 6761570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schedule-dependent synergism of combinations of hydroxyurea with adriamycin and 1-beta-D-arabinofuranosylcytosine with adriamycin.
    Ritch PS; Occhipinti SJ; Cunningham RE; Shackney SE
    Cancer Res; 1981 Oct; 41(10):3881-4. PubMed ID: 7284997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of dephosphorylation in accumulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in human lymphoblastic cell lines with reference to their drug sensitivity.
    Abe I; Saito S; Hori K; Suzuki M; Sato H
    Cancer Res; 1982 Jul; 42(7):2846-51. PubMed ID: 7083175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of the DNA breakage and cytotoxic effects of intercalating agents by treatment with sublethal doses of 1-beta-D-arabinofuranosylcytosine or hydroxyurea in L1210 cells.
    Minford J; Kerrigan D; Nichols M; Shackney S; Zwelling LA
    Cancer Res; 1984 Dec; 44(12 Pt 1):5583-93. PubMed ID: 6208999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase in Ara-C sensitivity in Ara-C sensitive and -resistant leukemia by stimulation of the salvage and inhibition of the de novo pathway.
    Colly LP; Richel DJ; Arentsen-Honders MW; Kester MG; ter Riet PM; Willemze R
    Ann Hematol; 1992 Jul; 65(1):26-32. PubMed ID: 1643157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cis-diammine-1,1-cyclobutane dicarboxylatoplatinum(II)-induced DNA interstand cross-link removal and potentiation of cis-diammine-1,1-cyclobutane dicarboxylatoplatinum(II) cytotoxicity by hydroxyurea and 1-beta-D-arabinofuranosylcytosine.
    Swinnen LJ; Ellis NK; Erickson LC
    Cancer Res; 1991 Apr; 51(8):1984-9. PubMed ID: 2009517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential modulation of 1-beta-D-arabinofuranosylcytosine metabolism by hydroxyurea in human leukemic cell lines.
    Kubota M; Takimoto T; Tanizawa A; Akiyama Y; Mikawa H
    Biochem Pharmacol; 1988 May; 37(9):1745-9. PubMed ID: 2454114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence-dependent interaction of 5-fluorouracil and arabinosyl-5-azacytosine or 1-beta-D-arabinofuranosylcytosine.
    Grem JL; Allegra CJ
    Biochem Pharmacol; 1991 Jul; 42(2):409-18. PubMed ID: 1713459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and cytokinetic modulation of L1210 and HL-60 cells by hydroxyurea and effect on 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity.
    Rauscher F; Cadman E
    Cancer Res; 1983 Jun; 43(6):2688-93. PubMed ID: 6189585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-dependent cytokinetic changes following 1-beta-D-arabinofuranosylcytosine and hydroxyurea in L1210 and S-180 in vivo.
    Straus MJ; Moran RE
    Cell Tissue Kinet; 1978 Sep; 11(5):529-42. PubMed ID: 299719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the effect of 1-beta-D-arabinofuranosylcytosine by 6-mercaptopurine in L1210 cells.
    Kawai Y; Ueda T; Nakamura T
    Jpn J Cancer Res; 1994 Sep; 85(9):978-85. PubMed ID: 7961129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.